Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial
Carmel T Collins, Robert A Gibson, Peter J Anderson, Andrew J McPhee, Thomas R Sullivan, Jacqueline F Gould, Philip Ryan, Lex W Doyle, Peter G Davis, Judy E McMichael, Noel P French, Paul B Colditz, Karen Simmer, Scott A Morris, Maria Makrides
BMJ Open | BMJ PUBLISHING GROUP | Published : 2015
Awarded by National Health and Medical Research Council (NHMRC), Australia
Awarded by NHMRC
This work was supported by a 5-year project grant from the National Health and Medical Research Council (NHMRC), Australia (ID 508003) and Mead Johnson Nutrition. CTC is supported through a MS McLeod Postdoctoral Research Fellowship (MS McLeod Research Fund, Women's and Children's Hospital Research Foundation); NHMRC Fellowships support RAG (Senior Principal Research Fellow APP1046207), PJA (Senior Research Fellow APP628371), PGD (Practitioner Fellow APP1059111), PBC (Practitioner Fellow APP511117), MM (Principal Research Fellow APP1061704).